Toll-like receptor 3 promotes cross-priming to virus-infected cells

被引:699
|
作者
Schulz, O
Diebold, SS
Chen, M
Näslund, TI
Nolte, MA
Alexopoulou, L
Azuma, YT
Flavell, RA
Liljeström, P
Sousa, CRE
机构
[1] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England
[2] Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden
[3] Swedish Inst Infect Dis Control, Dept Vaccine Res, S-17177 Stockholm, Sweden
[4] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[5] Howard Hughes Med Inst, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nature03326
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cross-presentation of cell-associated antigens plays an important role in regulating CD8(+) T cell responses to proteins that are not expressed by antigen-presenting cells (APCs)(1). Dendritic cells are the principal cross-presenting APCs in vivo and much progress has been made in elucidating the pathways that allow dendritic cells to capture and process cellular material(1). However, little is known about the signals that determine whether such presentation ultimately results in a cytotoxic T cell (CTL) response (cross-priming) or in CD8(+) T cell inactivation (cross-tolerance). Here we describe a mechanism that promotes cross-priming during viral infections. We show that murine CD8alpha(+) dendritic cells are activated by double-stranded (ds)RNA present in virally infected cells but absent from uninfected cells. Dendritic cell activation requires phagocytosis of infected material, followed by signalling through the dsRNA receptor, toll-like receptor 3 (TLR3). Immunization with virus-infected cells or cells containing synthetic dsRNA leads to a striking increase in CTL cross-priming against cell-associated antigens, which is largely dependent on TLR3 expression by antigen-presenting cells. Thus, TLR3 may have evolved to permit cross-priming of CTLs against viruses that do not directly infect dendritic cells.
引用
收藏
页码:887 / 892
页数:6
相关论文
共 50 条
  • [41] The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection
    El-Bendary, M.
    Neamatallah, M.
    Elalfy, H.
    Besheer, T.
    Elkholi, A.
    El-Diasty, M.
    Elsareef, M.
    Zahran, M.
    El-Aarag, B.
    Gomaa, A.
    Elhammady, D.
    El-Setouhy, M.
    Hegazy, A.
    Esmat, G.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2018, 75 (04) : 175 - 181
  • [42] Cross regulation of C3a receptor function by Toll-like receptor 2 in human mast cells
    Zaidi, Asifa K.
    Thangam, E. Berla
    Ali, Hydar
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S80 - S80
  • [43] Polarization of Adipose-Derived Mesenchymal Stem/Stromal Cells by Toll-Like Receptor Priming
    Rivera-Cruz, Cosette M.
    Figueiredo, Marxa L.
    FASEB JOURNAL, 2019, 33
  • [44] Activation of Toll-Like Receptor 2 Promotes Proliferation of Human Lung Adenocarcinoma Cells
    Gergen, Anna K.
    Kohtz, Patrick D.
    Halpern, Alison L.
    Li, Anqi
    Meng, Xianzhong
    Reece, T. Brett
    Fullerton, David A.
    Weyant, Michael J.
    ANTICANCER RESEARCH, 2020, 40 (10) : 5361 - 5369
  • [45] Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5
    Song, Eun-Jung
    Kang, Min-Jung
    Kim, Yong-Seok
    Kim, Sun-Moon
    Lee, Sang-Eok
    Kim, Chang-Hwan
    Kim, Dong-Jae
    Park, Jong-Hwan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (01) : 115 - 119
  • [46] TOLL-LIKE RECEPTOR SIGNALING IN CHONDROCYTE PROMOTES THE DEVELOPMENT OF OSTEOARTHRITIS
    Shen, P.
    Fuchs, M.
    Reisener, M. -J.
    Grinner, C.
    Wu, P.
    Jung, T.
    Pumberger, M.
    Parka, C.
    Loehning, M.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S378 - S379
  • [47] Toll-like receptor 4: A regulator of apoptosis in the infected cornea
    McClellan, Sharon
    Jiang, Xiaoyu
    Zhang, Yunfan
    Vistisen, Kerry
    Barrett, Ronald
    Hazlett, Linda
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [48] Toll-like Receptor 4 Signaling Promotes Tumor Growth
    Lee, Che-Hsin
    Wu, Chao-Liang
    Shiau, Ai-Li
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (01) : 73 - 82
  • [49] Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
    Salaun, Bruno
    Lebecque, Serge
    Matikainen, Sampsa
    Rimoldi, Donata
    Romero, Pedro
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4565 - 4574
  • [50] Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy
    Matsumoto, Misako
    Takeda, Yohei
    Seya, Tsukasa
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (08) : 937 - 946